⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACXP News
Acurx Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ACXP
From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television
accessnewswire.com
BIVI
CAST
SWRD
ACXP
BSIN
TMC
RDZN
Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect
prnewswire.com
ACXP
Form 8-K
sec.gov
ACXP
Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
accessnewswire.com
ACXP
New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global
accessnewswire.com
BIVI
ACXP
LTRN
Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. Vancomycin and Fidaxomicin (Standards of Care) in Clostridioides difficile and
prnewswire.com
ACXP
Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
prnewswire.com
ACXP
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
prnewswire.com
ACXP
Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
prnewswire.com
ACXP